ZFIN ID: ZDB-PUB-180509-1
The idebenone metabolite QS10 restores electron transfer in complex I and coenzyme Q defects
Giorgio, V., Schiavone, M., Galber, C., Carini, M., Da Ros, T., Petronilli, V., Argenton, F., Carelli, V., Acosta Lopez, M.J., Salviati, L., Prato, M., Bernardi, P.
Date: 2018
Source: Biochimica et biophysica acta   1859(9): 901-908 (Journal)
Registered Authors: Argenton, Francesco, Schiavone, Marco
Keywords: Complex I, Electron transfer, Idebenone, Respiration, Ubiquinone
MeSH Terms:
  • Adenosine Triphosphate/metabolism
  • Animals
  • Antioxidants/chemistry
  • Antioxidants/pharmacology
  • Ataxia/metabolism*
  • Ataxia/pathology
  • Cell Respiration
  • Cells, Cultured
  • Electron Transport
  • Electron Transport Complex I/deficiency
  • Electron Transport Complex I/metabolism*
  • Embryo, Nonmammalian/cytology
  • Embryo, Nonmammalian/drug effects
  • Embryo, Nonmammalian/metabolism*
  • Mice
  • Mitochondria, Liver/drug effects
  • Mitochondria, Liver/metabolism*
  • Mitochondrial Diseases/metabolism*
  • Mitochondrial Diseases/pathology
  • Muscle Weakness/metabolism*
  • Muscle Weakness/pathology
  • Ubiquinone/analogs & derivatives*
  • Ubiquinone/chemistry
  • Ubiquinone/deficiency*
  • Ubiquinone/metabolism
  • Ubiquinone/pharmacology
  • Zebrafish/embryology
  • Zebrafish/metabolism*
PubMed: 29694828 Full text @ Biochim. Biophys. Acta
Idebenone is a hydrophilic short-chain coenzyme (Co) Q analogue, which has been used as a potential bypass of defective complex I in both Leber Hereditary Optic Neuropathy and OPA1-dependent Dominant Optic Atrophy. Based on its potential antioxidant effects, it has also been tested in degenerative disorders such as Friedreich's ataxia, Huntington's and Alzheimer's diseases. Idebenone is rapidly modified but the biological effects of its metabolites have been characterized only partially. Here we have studied the effects of quinones generated during in vivo metabolism of idebenone with specific emphasis on 6-(9-carboxynonyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone (QS10). QS10 partially restored respiration in cells deficient of complex I or of CoQ without inducing the mitochondrial permeability transition, a detrimental effect of idebenone that may offset its potential benefits [Giorgio et al. (2012) Biochim. Biophys. Acta 1817: 363-369]. Remarkably, respiration was largely rotenone-insensitive in complex I deficient cells and rotenone-sensitive in CoQ deficient cells. These findings indicate that, like idebenone, QS10 can provide a bypass to defective complex I; and that, unlike idebenone, QS10 can partially replace endogenous CoQ. In zebrafish (Danio rerio) treated with rotenone, QS10 was more effective than idebenone in allowing partial recovery of respiration (to 40% and 20% of the basal respiration of untreated embryos, respectively) and allowing zebrafish survival (80% surviving embryos at 60 h post-fertilization, a time point at which all rotenone-treated embryos otherwise died). We conclude that QS10 is potentially more active than idebenone in the treatment of diseases caused by complex I defects, and that it could also be used in CoQ deficiencies of genetic and acquired origin.